What class of medication is Procardia (verapamil)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Procardia is a Dihydropyridine Calcium Channel Blocker (Nifedipine)

Procardia is the brand name for nifedipine, a dihydropyridine calcium channel blocker used primarily for hypertension and angina. 1

Important Clarification

The expanded question contains an error: Procardia is NOT verapamil. These are two distinct medications within the calcium channel blocker class:

  • Procardia (nifedipine): Dihydropyridine calcium channel blocker
  • Verapamil: Non-dihydropyridine (phenylalkylamine) calcium channel blocker

Key Differences Between These Drug Classes

Procardia/Nifedipine (Dihydropyridine)

  • Primary mechanism: Peripheral vasodilation through vascular smooth muscle calcium channel blockade 1
  • Cardiovascular effects: Decreases systemic vascular resistance and blood pressure; minimal direct cardiac effects 1
  • Does NOT significantly affect: SA node function, AV conduction, or heart rate in clinical use 1
  • Main uses: Hypertension and stable angina 1

Verapamil (Non-dihydropyridine)

  • Primary mechanism: Affects both vascular smooth muscle AND cardiac tissue (SA/AV nodes) 2
  • Cardiovascular effects: Slows AV nodal conduction, negative inotropic effects, AND vasodilation 2, 3
  • Main uses: Supraventricular tachycardia, rate control in atrial fibrillation, hypertension, angina 2, 4

Clinical Implications

This distinction is critical because these medications have different contraindications and clinical applications:

  • Procardia/nifedipine can be used in patients with AV block or bradycardia (no significant nodal effects) 1
  • Verapamil is contraindicated in AV block >1st degree, SA node dysfunction, decompensated heart failure, and should not be combined with beta-blockers in many situations 2

Metabolism and Drug Interactions

Both medications are CYP3A4 substrates, but this is particularly relevant for nifedipine:

  • Strong CYP3A4 inhibitors (ketoconazole, clarithromycin, grapefruit juice) increase nifedipine exposure significantly 1
  • Strong CYP3A4 inducers (rifampin, phenytoin, carbamazepine) are contraindicated with nifedipine 1
  • Dose adjustment required when initiating with CYP3A4 inhibitors 1

Common Pitfall

Do not confuse Procardia (nifedipine) with verapamil or diltiazem. Only the non-dihydropyridines (verapamil, diltiazem) have significant antiarrhythmic properties and AV nodal blocking effects. Nifedipine is purely a vasodilator without clinically significant cardiac conduction effects.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.